Duba zuwa sashi na ƙasa sannan ka amsa tambayar daga baya a cikin wannan harshe kamar yadda sashi: Passage: Gwaje-gwajen da aka zaɓa don bincika jinin mai ba da jini da nama dole ne su ba da babban matakin amincewa cewa za a gano cutar kanjamau idan akwai (watau, ana buƙatar babban ƙwarewa). Ana amfani da haɗuwa da gwaje-gwajen antibody, antigen da nucleic acid ta bankuna na jini a ƙasashen Yammacin duniya. Hukumar Lafiya ta Duniya ta kiyasta cewa, tun daga shekara ta 2000, rashin isasshen gwajin jini ya haifar da sabbin kamuwa da cutar kanjamau miliyan 1 a duk duniya.A Amurka, Hukumar Abinci da Magunguna ta buƙaci cewa a bincika duk jinin da aka bayar don cututtukan cututtuka da yawa, gami da HIV-1 da HIV-2, ta amfani da haɗuwa da gwajin antibody (EIA) da ƙarin gwajin nucleic acid (NAT). Waɗannan gwaje-gwajen na bincike suna haɗuwa da zaɓin mai ba da hankali. A shekara ta 2001, haɗarin kamuwa da cutar kanjamau da cutar kanjamau a Amurka ya kai kimanin mutum ɗaya cikin
daya cikin miliyan 2.5